Covid 19 Clinical Trials

	Name (Synonyms)	Correlation
D000070642	Brain Injuries, Traumatic NIH	0.45
D001930	Brain Injuries, NIH	0.38
D040921	Stress Disorders, Traumatic NIH	0.22
D013313	Stress Disorders, Post-Traumatic NIH	0.20
D004194	Disease NIH	0.18

Correlated HPO Terms (0)

	Name (Synonyms)	Correlation

There is one clinical trial.

Clinical Trials

1 A Structural HIV Prevention Intervention Targeting High-risk Women

The purpose of this study is to assess the effectiveness of a community based combination HIV prevention package, including biomedical, behavioral, and structural services for female sex workers (FSW) in Baltimore, Maryland. This study is a prospective two-group trial comparing the efficacy of a community-based comprehensive HIV/STI prevention package compared to standard of care (HIV testing, counseling, and referrals) among FSWs. Outcomes will be assessed through self-reported illicit drug use and sexual risk behaviors (behavioral) as well as HIV/STI testing (biological).

NCT04413591 Sex Work Behavioral: Community based combination HIV prevention package

Primary Outcomes

Description: Participants will be tested for HIV, chlamydia and gonorrhea at each study visit.

Measure: Change in HIV/STI cumulative incidence over time

Time: Baseline, 6 month, 12 month, 18 month, 24 month visits.

Secondary Outcomes

Description: Participants will be asked for detailed information about sexual partners in the last 6 months. For each listed partner, the investigators will ask: gender; age; drug use; incarceration history; type of partner (primary, casual, one-time); frequency of sexual activity and condom use; type of sex (oral, vaginal, anal); and if partner had other sexual partners during the time of their sexual involvement. This data collection method allows for calculation of the number of unprotected sexual acts.

Measure: Sexual Risk Behaviors

Time: Baseline, 6 month, 12 month, 18 month visits.

Description: The investigators will ascertain the initiation and frequency of all illicit drugs through the use of a modified NIDA Risk Assessment Battery that has been used and adapted over the past decade.

Measure: Illicit Drug Use

Time: Baseline, 6 month, 12 month, 18 month visits.

Other Outcomes

Description: SPARC Center client satisfaction surveys will be used to determine the fit, facilitators and barriers, quality, and general experience of women who have used the SPARC Center.

Measure: Implementation evaluation using SPARC Center client satisfaction surveys

Time: 12-month, 18-month

Description: An in-depth interview guide will be developed by experienced study staff and used to interview SPARC guests and staff with the goal of examining program reach, fit, facilitators and barriers, and program costs.

Measure: Implementation evaluation using in-depth interviews with SPARC staff and clients

Time: 18 months

Description: A cross-sectional survey will be developed by study staff and used to determine the reach of the implementation within the FSW community of southwest Baltimore.

Measure: Implementation evaluation using cross-sectional surveys

Time: 18 months

CovidResearchTrials by Shray Alag

Covid 19 Research using Clinical Trials (Home Page)

Community based combination HIV prevention packageWiki

Developed by Shray Alag

Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation

Correlated Drug Terms (2)

Correlated MeSH Terms (5)